Bioatla Stock Net Income
| BCAB Stock | USD 0.43 0.10 18.87% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Bioatla's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -62.8 M | -65.9 M | |
| Net Loss | -95.8 M | -91 M | |
| Net Loss | -62.8 M | -65.9 M | |
| Net Loss | (1.65) | (1.73) | |
| Net Income Per E B T | 0.89 | 0.79 |
Bioatla | Net Income | Build AI portfolio with Bioatla Stock |
Bioatla Company Net Income Analysis
Bioatla's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Bioatla Net Income | (69.78 M) |
Most of Bioatla's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioatla is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bioatla Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Bioatla is extremely important. It helps to project a fair market value of Bioatla Stock properly, considering its historical fundamentals such as Net Income. Since Bioatla's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bioatla's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bioatla's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Bioatla reported net income of (69.78 Million). This is 120.45% lower than that of the Biotechnology sector and 199.61% lower than that of the Health Care industry. The net income for all United States stocks is 112.22% higher than that of the company.
Bioatla Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioatla's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bioatla could also be used in its relative valuation, which is a method of valuing Bioatla by comparing valuation metrics of similar companies.Bioatla is currently under evaluation in net income category among its peers.
Bioatla Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bioatla from analyzing Bioatla's financial statements. These drivers represent accounts that assess Bioatla's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bioatla's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 1.1B | 678.4M | 117.5M | 28.7M | 33.0M | 31.4M | |
| Enterprise Value | 907.0M | 438.8M | 8.5M | (19.5M) | (22.4M) | (21.3M) |
Bioatla Institutional Holders
Institutional Holdings refers to the ownership stake in Bioatla that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bioatla's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bioatla's value.| Shares | Marshall Wace Asset Management Ltd | 2025-06-30 | 80.8 K | Susquehanna International Group, Llp | 2025-06-30 | 74.8 K | Magnus Financial Group Llc | 2025-06-30 | 47.2 K | Mccormack Advisors International | 2025-06-30 | 44.3 K | Alpha Cubed Investments Llc | 2025-06-30 | 41.1 K | National Asset Management Inc | 2025-06-30 | 30 K | Ubs Group Ag | 2025-06-30 | 29.6 K | Columbia Advisory Partners Llc | 2025-06-30 | 26.1 K | Commonwealth Equity Services Inc | 2025-06-30 | 25.3 K | Vanguard Group Inc | 2025-06-30 | 1.8 M | Tang Capital Management Llc | 2025-06-30 | 1.4 M |
Bioatla Fundamentals
| Return On Equity | -8.14 | ||||
| Return On Asset | -1.05 | ||||
| Current Valuation | 29.27 M | ||||
| Shares Outstanding | 58.79 M | ||||
| Shares Owned By Insiders | 11.07 % | ||||
| Shares Owned By Institutions | 28.65 % | ||||
| Number Of Shares Shorted | 4.34 M | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 4.22 X | ||||
| Revenue | 11 M | ||||
| Gross Profit | (46.73 M) | ||||
| EBITDA | (73.02 M) | ||||
| Net Income | (69.78 M) | ||||
| Cash And Equivalents | 178.12 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 836 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 7.48 X | ||||
| Book Value Per Share | (0.53) X | ||||
| Cash Flow From Operations | (71.94 M) | ||||
| Short Ratio | 2.26 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 61 | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 31.41 M | ||||
| Total Asset | 52.42 M | ||||
| Retained Earnings | (486.04 M) | ||||
| Working Capital | 36.69 M | ||||
| Net Asset | 52.42 M |
About Bioatla Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioatla's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioatla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioatla based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Bioatla Piotroski F Score and Bioatla Altman Z Score analysis. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.